Pat Soon-Shiong Shares a Study on Lymphopenia and its Link to Mortality Risk
Photo: metro-connect-usa.com

Pat Soon-Shiong Shares a Study on Lymphopenia and its Link to Mortality Risk

Pat Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman at ImmunityBio, and Executive Chairman of the Los Angeles Times, shared a post on X:

“In 2019, Zidar et al., published in JAMA, “Association of Lymphopenia With Risk of Mortality Among Adults in the US General Population‘ and reported that low lymphocyte levels are associated with reduced survival in the United States general population.

Their study highlighted that “based on these findings, patients with lymphopenia, especially those with other immunohematologic abnormalities, may have excess mortality risk; these patients are readily identifiable because tests of lymphocyte levels often occur during routine medical encounters’. Furthermore, the importance of this finding was emphasized by the following statement, “Immune dysregulation can increase the risk of infection, malignant neoplasms, and cardiovascular disease, but improved methods are needed to identify and quantify immunologic hazard in the general population.’ ”

More posts featuring Pat Soon-Shiong.